Assessment of Psychiatric Disorders Via PET Scan

Publish Year: 1403
نوع سند: مقاله کنفرانسی
زبان: English
View: 3

متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

CMPS01_138

تاریخ نمایه سازی: 17 خرداد 1405

Abstract:

Background: Positron Emission Tomography (PET) imaging is revolutionizing the study of psychiatric disorders by enabling the visualization of underlying neurobiological mechanisms. Psychiatric conditions such as depression, schizophrenia, and bipolar disorder often involve neuroinflammation and altered neurotransmitter systems, which PET imaging can map with precision. This approach offers critical insights into the diagnosis, monitoring, and personalization of treatment for these complex disorders. Materials and Methods: To explore the role of PET imaging in psychiatric disorders, a systematic review was conducted using databases such as PubMed and Scopus. Search keywords included "PET imaging," "psychiatric disorders," and "neuroinflammation." Relevant studies were identified and analyzed to highlight advancements, applications, and challenges in this field. Results: Neuroinflammation, a key feature of psychiatric disorders, can be effectively detected using radioligands targeting the translocator protein (TSPO), a biomarker of microglial activation. PET imaging of TSPO has revealed inflammation patterns in disorders like major depressive disorder and schizophrenia, improving the understanding of their pathophysiology. PET-MRI hybrid systems further enhance diagnostic precision by combining PET's functional imaging with MRI's anatomical detail. This integration supports comprehensive evaluations, such as identifying structural and functional changes in bipolar disorder and frontotemporal dementia. However, challenges persist, including variability in TSPO expression, high costs, and the need for improved radiotracers. Conclusion: PET imaging has advanced our understanding of psychiatric disorders by providing detailed insights into neuroinflammatory processes and functional brain changes. Despite limitations, ongoing innovations in radiotracer technology and multimodal imaging systems promise broader clinical applicability. These advancements position PET imaging as a key tool for personalized psychiatric diagnostics and treatment.

Authors

Amirabbas Heydari

Radiology Technology Department, Faculty of Para medicine, AJA University of Medical Sciences, Tehran, Iran

Hamed Faraj Mohammadloo

Radiology Technology Department, Faculty of Para medicine, AJA University of Medical Sciences, Tehran, Iran

Parsa Mokhtari

Radiology Technology Department, Faculty of Para medicine, AJA University of Medical Sciences, Tehran, Iran

Mohammad Reza Homayouni

Radiology Technology Department, Faculty of Para medicine, AJA University of Medical Sciences, Tehran, Iran